KOLINSKI STUART 4
4 · REGENERON PHARMACEUTICALS INC · Filed Jan 29, 2010
Insider Transaction Report
Form 4
KOLINSKI STUART
SVP General Counsel and Secret
Transactions
- Sale
Common Stock
2010-01-27$27.00/sh−4,359$117,693→ 10,613 total - Exercise/Conversion
Incentive Stock Option (right to buy)
2010-01-27−4,359→ 0 totalExercise: $8.50Exp: 2011-01-05→ Common Stock (4,359 underlying) - Exercise/Conversion
Common Stock
2010-01-27$8.50/sh+4,359$37,052→ 14,972 total
Holdings
- 3,294(indirect: By 401(k))
Common Stock
Footnotes (3)
- [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- [F2]The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
- [F3]Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is not applicable in this case.